Doloteffin – clinically proven efficacy
Different pain syndromes respond to Doloteffin 3
The results of 3 surveillance studies 1,2,3 suggest that up to 75% of patients with back pain or painful arthroses satisfy the concensus criterion of the large orthopaedic societies OMERACT and OARSI during a one-year treatment with the aqueous Devil’s Claw extract Doloteffin and that various pain syndromes (acute exaccerbations of chronic back pain, hip arthroses and/or knee arthroses pain) respond to Doloteffin to the same extent. 3
Improvement in weekly pain scores
1) Chrubasik et al. Rheumatology 2003; 42:141-148.
2) Chrubasik et al. Phytomedicine 2005; 12 :1-9.
3) Chrubasik et al. Phytomedicine 2002; 9:181-194.